# Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Study · id `cardio:ct-nct01617681` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01617681](<https://clinicaltrials.gov/study/NCT01617681>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01617681

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 127 participants.

## Technical summary

Registry record NCT01617681. Randomized; triple masking; primary purpose treatment. Start 2012-11-08 (actual); primary completion 2017-01-24 (actual). Results posted on 2017-09-27.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 127 participants (enrolled count; ClinicalTrials.gov record NCT01617681, source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)
- Started: 2012-11-08 (actual) (ClinicalTrials.gov record NCT01617681, source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)
- Primary completion: 2017-01-24 (actual) (ClinicalTrials.gov record NCT01617681, source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)
- Completion: 2017-01-24 (actual) (ClinicalTrials.gov record NCT01617681, source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)
- Results first posted: 2017-09-27 (ClinicalTrials.gov record NCT01617681, source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)
- Countries: Belgium; Brazil; France; Germany; Guatemala; Hungary; Italy; Lithuania; Poland (ClinicalTrials.gov record NCT01617681, source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01617681-2017-09-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
- Condition: Pediatric Hypertension With or Without CKD
- Intervention (Drug): VAL489
- Intervention (Drug): VAL489 matching placebo
- Lead sponsor: Novartis Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Novartis (`cardio:novartis`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: a randomized, double-blind study followed by open-label phase (`cardio:pubmed-34543161`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6294318962e86b753c587b9a1216a9d34b6fce9c784f0b0b498ba3f2290a22f7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
